I strongly suggest you read first:

I strongly suggest you read first:

https://investors.gamida-cell.com/static-files/b78877cc-4a35-499a-ada7-f8decd6e1283

See this:

~13,000 patients with hematologic malignancies are eligible
for transplant annually in the U.S.

With other figures from different sources you can find the
total market, than figure out the market share GMDA can
cappture.

In other words, do not expect me to do the DD for you.



GLTY